Top 10 Companies in the Southeast Asia Pharma Grade Soybean Oil Market (2026): Market Leaders Powering Regional Pharmaceutical Innovation

MARKET INSIGHTS

Global Southeast Asia Pharma Grade Soybean Oil market was valued at USD 156.8 million in 2023 and is projected to reach USD 223.4 million by 2030, exhibiting a CAGR of 5.2% during the forecast period.

Pharma grade soybean oil is a highly refined vegetable oil that meets stringent pharmacopeia standards for purity and safety. This specialized oil serves as an excipient in pharmaceutical formulations, functioning as a solvent, emulsifier, or carrier for active pharmaceutical ingredients (APIs). The production process involves multiple purification steps including degumming, neutralization, bleaching, and deodorization to remove impurities and achieve required pharmaceutical specifications.

The market growth is fueled by increasing pharmaceutical manufacturing in Southeast Asia, rising demand for parenteral nutrition formulations, and expanding applications in topical preparations. However, stringent regulatory requirements for pharmaceutical excipients and competition from alternative lipid-based carriers present challenges to market expansion. Recent innovations include the development of high‑oleic soybean oil variants offering improved oxidative stability for extended shelf‑life pharmaceutical products.

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

---

1️⃣ 1. Cargill Incorporated

Headquarters: Chicago, Illinois, USA
Key Offering: Pharma‑grade soybean oil for injection, oral, and topical applications

Cargill’s extensive global supply chain and long‑standing expertise in food and pharmaceutical excipients position it as a trusted supplier for regional manufacturers. Its GMP‑certified facilities in Thailand and Vietnam provide a consistent feedstock for injectable lipid emulsions and softgel capsules.

Sustainability & Growth Initiatives:

• Investment in renewable soybean sourcing and traceability platforms
• Partnerships with local growers to secure non‑GMO, high‑yield soybeans
• Adoption of advanced refining technologies to reduce peroxide levels by 15%

2️⃣ 2. Archer Daniels Midland Company

Headquarters: Chicago, Illinois, USA
Key Offering: High‑purity soybean oil for pharmaceutical and nutraceutical markets

ADM leverages its integrated agricultural processing operations to deliver oil that meets USP and EP standards. Its regional plants in Malaysia and Indonesia focus on cost‑efficient production while maintaining strict quality controls.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop water recycling in refining units
• Collaboration with the ASEAN Bio‑economy Initiative for shared sustainability metrics
• Development of high‑oleic soybean variants tailored for vaccine formulations

3️⃣ 3. AAK AB

Headquarters: Lund, Sweden
Key Offering: Specialty oils for pharmaceutical excipients, including high‑purity soybean oil

AAK’s specialty oils division supplies niche segments, providing customized formulations for monoclonal antibody carriers and lipid nanoparticle vaccines. Its European base allows rapid technology transfer to ASEAN partners.

Sustainability & Growth Initiatives:

• Carbon‑neutral refining processes across all facilities
• Investment in high‑oleic soybean breeding programs
• Partnerships with local universities for process optimization research

4️⃣ 4. IOI Corporation Berhad

Headquarters: Kuala Lumpur, Malaysia
Key Offering: Pharma‑grade soybean oil for injectable and oral dosage forms

IOI’s vertically integrated model—from soybean cultivation to refining—ensures tight control over quality and supply. The company’s halal certification aligns with regional market demands.

Sustainability & Growth Initiatives:

• Adoption of precision agriculture to reduce pesticide usage by 20%
• Expansion of its refinery capacity to 150,000 tons per year
• Launch of a digital traceability platform for raw‑material sourcing

5️⃣ 5. Patum Vegetable Oil Co., Ltd.

Headquarters: Bangkok, Thailand
Key Offering: USP/EP compliant soybean oil for injectable emulsions and softgel capsules

Patum’s proximity to Thailand’s major pharmaceutical hubs allows rapid response to local demand spikes. Its focus on low‑peroxide oil meets the stringent requirements of injectable formulations.

Sustainability & Growth Initiatives:

• Investment in renewable energy for refining operations
• Collaboration with Thai government on sustainable soybean farming programs
• Development of ultra‑refined oil fractions for mRNA vaccine delivery

6️⃣ 6. Wilmar International Limited

Headquarters: Singapore
Key Offering: High‑purity soybean oil for pharmaceutical and nutraceutical applications

Wilmar’s Singaporean base provides strategic access to both regional and global markets. Its portfolio includes a range of purity grades to satisfy diverse regulatory environments.

Sustainability & Growth Initiatives:

• Carbon‑intensity reduction targets of 25% by 2030
• Implementation of blockchain for supply‑chain transparency
• Partnerships with ASEAN universities for research on high‑oleic soybean breeding

7️⃣ 7. Musim Mas Holdings

Headquarters: Singapore
Key Offering: Pharma‑grade soybean oil with USP and JP compliance

Musim Mas focuses on delivering premium quality oils for both injectable and oral dosage forms. Its regional presence supports rapid scaling in emerging markets.

Sustainability & Growth Initiatives:

• Adoption of green hydrogen for energy in refining units
• Engagement with local farmers to promote sustainable soybean cultivation
• Investment in next‑generation purification technologies to lower heavy‑metal content

8️⃣ 8. KLK Oleo

Headquarters: Kuala Lumpur, Malaysia
Key Offering: High‑purity soybean oil for pharmaceutical excipients

KLK Oleo’s focus on niche pharmaceutical applications has positioned it as a preferred supplier for contract manufacturers seeking USP‑grade oils.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop water recycling systems
• Partnership with Malaysian Ministry of Agriculture for sustainable soybean sourcing
• Development of high‑oleic soybean oil for lipid nanoparticle vaccines

9️⃣ 9. Bunge Limited

Headquarters: Irving, Texas, USA
Key Offering: Pharmaceutical‑grade soybean oil for injectable and oral applications

Bunge’s global footprint and advanced refining capabilities allow it to supply consistent, high‑purity oils across Southeast Asia, supporting both domestic and export markets.

Sustainability & Growth Initiatives:

• Carbon‑neutral refining processes across all facilities
• Investment in high‑oleic soybean breeding for improved oxidative stability
• Collaboration with local governments to promote sustainable soybean farming

🔟 10. Fuji Oil Holdings Inc.

Headquarters: Tokyo, Japan
Key Offering: USP/EP compliant soybean oil for pharmaceutical and nutraceutical markets

Fuji Oil’s focus on quality and regulatory compliance makes it a reliable partner for manufacturers seeking to meet international pharmacopeia standards.

Sustainability & Growth Initiatives:

• Use of renewable energy sources for refining operations
• Partnerships with local farmers to reduce pesticide usage
• Investment in high‑oleic soybean breeding programs tailored to vaccine formulations

---

Download FREE Sample Report

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

---

Get Full Report

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

---

Outlook

From 2025 through 2034, the market is expected to maintain steady expansion, driven by the continued growth of regional pharmaceutical manufacturing and the increasing adoption of advanced excipient technologies. The shift toward localized production is likely to reduce lead times and enhance supply‑chain resilience, positioning suppliers that can meet both regulatory and quality demands for premium pricing.

---

Future Trends

• Localization of refining capacity in Thailand, Indonesia, and Vietnam to mitigate import dependency.
• Rise of high‑oleic soybean oil as a preferred carrier for lipid‑nanoparticle vaccines and cell‑therapy cryopreservation.
• Regulatory harmonization across ASEAN, accelerating the adoption of USP/EP standards and reducing compliance fragmentation.
• Integration of digital traceability and blockchain to assure end‑to‑end quality assurance for pharmaceutical excipients.
• Expansion of contract manufacturing organizations seeking premium, GMP‑certified soybean oil to support biologics and specialty drug production.